Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival
Mandeep R. Mehra, MD, FACC*,*,
Patricia A. Uber, PharmD*,
Krishnamoorthy Vivekananthan, MD*,
Sergio Solis, MD*,
Robert L. Scott, MD, FACC*,
Myung H. Park, MD*,
Richard V. Milani, MD, FACC* and
Carl J. Lavie, MD, FACC*
* Ochsner Clinic Foundation, New Orleans, Louisiana, USA
View larger version (13K):
[in a new window]
|
Figure 1 Rates of allograft rejection (%) between pravastatin (black bars) and simvastatin (white bars). HDC = hemodynamic compromise.
|
|
View larger version (13K):
[in a new window]
|
Figure 2 Comparison of average biopsy rejection scores. *p < 0.05 for simvastatin or pravastatin group compared with statin-naive groups.
|
|
|
